Practice Matters
Oncology Advanced Practitioners and Breast Cancer Prevention
Wendy H. Vogel,(1) MSN, FNP, AOCNP®, Haley Pace,(2) MS, CGC, and Matthew Brignola,(3) PharmD
From (1)Harborside, Huntington, New York; (2)InformedDNA, St. Petersburg, Florida; (3)Novant Health Cancer Institute Forsyth, Winston-Salem, North Carolina
Authors’ disclosures of conflicts of interest are found at the end of this article.
Correspondence to: Wendy H. Vogel, MSN, FNP, AOCNP®, Harborside, 94 North Woodhull Road, Huntington, NY 11743.
E-mail: wvogel@hbside.com
J Adv Pract Oncol 2020;11(8):863–870 |
https://doi.org/10.6004/jadpro.2020.11.8.6 |
© 2020 Harborside™
ABSTRACT
One in eight American women will be diagnosed with breast cancer. Advanced practitioners in oncology can offer risk assessments, counseling, genetic testing, and make both behavioral and pharmacologic recommendations for breast cancer risk reduction. The role of oncology advanced practitioners in conjunction with genetic counselors is key in what is now considered the standard of care. This article will summarize the current state of breast cancer prevention and the role of oncology advanced practitioners.
For access to the full length article, please
sign in.
